Arthur David J. 4
4 · Salarius Pharmaceuticals, Inc. · Filed Apr 12, 2024
Insider Transaction Report
Form 4
Arthur David J.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2024-04-11+20,500→ 20,500 totalExercise: $0.51From: 2025-04-11Exp: 2034-04-11→ Common Stock (20,500 underlying)